Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics, Genomics Projects among 131 Komen Foundation Grants

NEW YORK, June 9 - Genomics- and proteomics-related breast cancer research projects are among 131 grants totaling $21 million awarded by the Susan G. Komen Breast Cancer Foundation for fiscal year 2003.


The foundation announced the recipients of the grants during its Sixth Annual Mission Conference, held in Washington, DC, today.


The Komen Foundation Award and Research Grant Program is funded by 25 percent of all proceeds raised by Komen Affiliates and Komen Race for the Cure events across the country, as well as by private and corporate donations. Funds for the FY 2003 grants were raised over the course of 2002.


Some genomics and proteomics research projects supported by this year's grants include:


·         $249,956 for "Capture breast cancer early: Detecting ductal carcinoma in situ by serum proteomic analysis using ProteinChip arrays and SELDI-mass spectrometry," Jinong Li, Department of Pathology, Johns Hopkins University.

·         $250,000 for "Prospective study of the predictive power of surface-enhanced laser desorption ionization mass spectrometry in detecting early stage breast cancer," Peter Oefner, Stanford Genome Technology Center.

·         $250,000 for "Identification of Markers of Aggressive Breast Cancer by Large Cohort Tissue Microarrays," Harriet Kluger, Yale University.

·         $135,000 for "Identification and Characterization of Novel RAD6 Group Genes and Their Role in Genome Stability," Floyd Romesberg, Scripps Research Institute.


A complete list of FY 2003 grant recipients is available here.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.